Skip to main content

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1021223 LOS ANGELES, CA

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,750,909
-$1,731,336 QoQ
Shares Held
9,223
-4.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#373
of 1,322 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 52% Shared 46% None 1%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $15,557,323 across 9 Biotechnology names. REGN ranks #2 (37.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
9,223 $5,750,909

All Filings in REGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,750,909 9,223
2026-03-31 $7,482,245 9,684
2025-12-31 $7,221,615 9,356
2025-09-30 $5,221,800 9,287
2025-06-30 $4,709,250 8,970
2025-03-31 $5,432,814 8,566
2024-12-31 $3,759,676 5,278
2024-09-30 $6,040,424 5,746
2024-06-30 $5,945,675 5,657
2024-03-31 $4,229,180 4,394
2023-12-31 $3,613,284 4,114
2023-09-30 $3,514,038 4,270
2023-06-30 $3,091,158 4,302
2022-03-31 $2,095 3
2020-06-30 $4,365 7
2020-03-31 $3,418 7